Extension of Time to File SOU

N LOREM

Ionis Pharmaceuticals, Inc.

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 12/31/2020. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88519487
LAW OFFICE ASSIGNED LAW OFFICE 127
MARK SECTION
MARK N LOREM (see, http://uspto.report/TM/88519487/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT N LOREM
OWNER SECTION (current)
NAME Ionis Pharmaceuticals, Inc.
MAILING ADDRESS 2855 Gazelle Court
CITY Carlsbad
STATE California
ZIP/POSTAL CODE 92010
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
OWNER SECTION (proposed)
NAME Ionis Pharmaceuticals, Inc.
MAILING ADDRESS 2855 Gazelle Court
CITY Carlsbad
STATE California
ZIP/POSTAL CODE 92010
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Anne H. Peck
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@cooley.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) apeck@cooley.com; dkoons@cooley.com; bfocarino@cooley.com
CORRESPONDENCE INFORMATION (proposed)
NAME Anne H. Peck
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@cooley.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) apeck@cooley.com; dkoons@cooley.com; bfocarino@cooley.com
DOCKET/REFERENCE NUMBER 097721-20084
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION pharmaceutical preparations for the treatment of rare diseases
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 036
CURRENT IDENTIFICATION Charitable fundraising; charitable foundation services, namely, providing fundraising activities to support medical research and development for treatment of rare diseases
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 042
CURRENT IDENTIFICATION Research and development of pharmaceuticals for the treatment of rare diseases; Providing scientific research information in the fields of pharmaceuticals, therapies, and rare diseases
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 044
CURRENT IDENTIFICATION Charitable services, namely, patient assistance programs to provide drugs free of charge to patients of rare diseases without prescription drug coverage; Providing medical information in the field of pharmaceuticals, therapies, and rare diseases
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 08/04/2020
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 4
SUBTOTAL AMOUNT [EXTENSION FEE] 500
TOTAL AMOUNT 500
SIGNATURE SECTION
SIGNATURE /Clifford E Ford/
SIGNATORY'S NAME Clifford E. Ford
SIGNATORY'S POSITION Vice President, Patents and Senior Patent Counsel
DATE SIGNED 01/29/2021
SIGNATORY'S PHONE NUMBER 650 843 5000
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Mon Feb 01 12:21:15 ET 2021
TEAS STAMP USPTO/ESU-XX.XX.XXX.XX-20
210201122115136356-885194
87-76083fee05fa78acba9c4b
3192b94ac919e75ca2f56e567
a644e6d164fbcf393-DA-2113
7361-20210125103236862319



PTO- 1581
Approved for use through 12/31/2020. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: N LOREM (see, http://uspto.report/TM/88519487/mark.png)
SERIAL NUMBER: 88519487

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Ionis Pharmaceuticals, Inc., having an address of
      2855 Gazelle Court
      Carlsbad, California 92010
      United States
      Email: XXXX
Proposed: Ionis Pharmaceuticals, Inc., having an address of
      2855 Gazelle Court
      Carlsbad, California 92010
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 08/04/2020.

For International Class 005:
Current identification: pharmaceutical preparations for the treatment of rare diseases

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 036:
Current identification: Charitable fundraising; charitable foundation services, namely, providing fundraising activities to support medical research and development for treatment of rare diseases

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 042:
Current identification: Research and development of pharmaceuticals for the treatment of rare diseases; Providing scientific research information in the fields of pharmaceuticals, therapies, and rare diseases

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 044:
Current identification: Charitable services, namely, patient assistance programs to provide drugs free of charge to patients of rare diseases without prescription drug coverage; Providing medical information in the field of pharmaceuticals, therapies, and rare diseases

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

Correspondence Information (current):
      Anne H. Peck
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@cooley.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): apeck@cooley.com; dkoons@cooley.com; bfocarino@cooley.com

Correspondence Information (proposed):
      Anne H. Peck
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@cooley.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): apeck@cooley.com; dkoons@cooley.com; bfocarino@cooley.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $500 will be submitted with the form, representing payment for 4 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Clifford E Ford/      Date Signed: 01/29/2021
Signatory's Name: Clifford E. Ford
Signatory's Position: Vice President, Patents and Senior Patent Counsel
Signatory's Phone: 650 843 5000
Signature method: Sent to third party for signature

PAYMENT: 88519487
PAYMENT DATE: 02/01/2021

Serial Number: 88519487
Internet Transmission Date: Mon Feb 01 12:21:15 ET 2021
TEAS Stamp: USPTO/ESU-XX.XX.XXX.XX-20210201122115136
356-88519487-76083fee05fa78acba9c4b3192b
94ac919e75ca2f56e567a644e6d164fbcf393-DA
-21137361-20210125103236862319




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed